◀ Back to TGFB1

IFNB1 — TGFB1

Text-mined interactions from Literome

Ossege et al., Int Immunopharmacol 2001 (Multiple Sclerosis) : The present data suggest that IFN beta-1b induces the mRNA expression of TGF beta-1 and TGF beta-R-II by PBMC, decreases that of TNF alpha and increases levels of sVCAM-1 and of circulating activated CD8 cells ( CD8CD38 ) in blood
Tanabe et al., Immunology 2007 (Disease Progression...) : Furthermore, IFN-beta reduced the expressions of transforming growth factor-beta , basic fibroblast growth factor, collagen type I A2 and tissue inhibitor of metalloproteinase 1 messenger RNAs, which are related to the progression of liver fibrosis
Créange et al., BioDrugs 2000 : IFNbeta increases anti-inflammatory T cell functions and the production of anti-inflammatory cytokines, such as TGFbeta1
Zhang et al., Clin Neurol Neurosurg 2010 (Autoimmune Diseases...) : IFNbeta inhibited IL-1beta, IL-23 and transforming growth factor ( TGF ) -beta ( which induce Th17 cell differentiation ), and induced IL-27, IL-12p35 and IL-10 ( which suppress it ) in dendritic cells (DCs) and B-cells
Arnason et al., Clin Immunol Immunopathol 1996 (Autoimmune Diseases...) : Production of the suppressive cytokines IL-10 and transforming growth factor beta-1 is increased in vitro by IFNbeta1b
Arnason et al., J Neural Transm Suppl 1997 (Demyelinating Diseases...) : In contrast ; production of transforming growth factor beta-1 ( TGF beta 1 ) is increased by IFN beta-1b
Ossege et al., J Neuroimmunol 1998 (Multiple Sclerosis) : The present data suggest that IFNbeta-1b induces the expression of TGFbeta-1- and TGFbeta-R-II-mRNA by PBMC and increases levels of sVCAM-1 and of circulating activated CD8 cells ( CD8CD38 ) in serum